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The tissue distribution of the mRNAs encoding muscarinic acetylcholine receptors (mAChRs) I, II, III and IV has been 
investigated by blot hybridization analysis with specific probes. This study indicates that exocrine glands contain both 
mAChR I and III mRNAs, whereas smooth muscles contain both mAChR II and III mRNAs. All four mAChR mRNAs 
are present in cerebrum, whereas only mAChR II mRNA is found in heart. 
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1. INTRODUCTION 
The muscarinic acetylcholine receptor (mAChR) 
mediates a variety of cellular responses through the 
acticn of ~uanine uuc(eatide-B<u&& regu&ary 
proteins [l]. The primary structures of four 
molccnJar>y Befir& mhCbR s~b2ypes, bekgJx&l, 
mA(CbR I-3Y, >Ilave kxz e%x%kaJe~ by ckakg 
and sequence analysis of the cDNAs or genomic 
DNAs [2-81. The antagonist-binding properties of 
the individual mAChR subtypes expressed from 
the cloned DNAs in Xenopus oocytes [2,8,9] in- 
dicate that mAChR I-III correspond most closely 
to the pharmacologically defined Mi (I), MZ car- 
diac (II) and Mz glandular (III) subtypes [lo-121, 
respectively. The agonist-induced responses in 
Xenopus oocytes and mammalian cells expressing 
the individual mAChR species provide evidence 
that mAChR subtypes are selectively coupled with 
difftrp,?n p,Zti&, ~jy”;ri’,llr,, &%cil I~J; -u&~&&y 
[2,9,13-161. In order to gain a further insight into 
the molecular basis of the functional heterogeneity 
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of the mAChR, we have now examined the 
distribution of the four mAChR mRNAs in ex- 
ocrine glands, smooth muscles, heart and 
cerebrum, using RNA blot hybridization analysis 
w&h probes specific for c&e respedive mRNAs. 
Total RNA was extracted from tissues of pigs and male 
Wistar rats (-200 g body wt) by the guanidinium thiocyanate 
method [17], and poly(A)+ RNA was isolated as in [18]. The 
yield of poly(A)+ RNA during oligo(dT)-cellulose chromatog- 
raphy was 7-10% for all preparations. Samples of poly(A)+ 
RNA were denatured with 1 M glyoxal and 50% dimethyl 
sulphoxide [19], electrophoresed on 1.5% agarose gels and 
transferred [20] to Biodyne nylon membranes (Pall). The 
hybridization and washing conditions were the same as in [21], 
except that the concentration of each probe was 5 ng/ml. The 
mAChR subtype-specific probes were restriction fragments cor- 
responding to regions with unique amino acid sequences located 
between the putative transmembrane segments V and VI; for 
$pr.&iP~ <:tlL- &o%?isL~ <rnA.GhP ,’ ‘rnR?Ep., ‘? .rpy;f~iSj?r A-L?@z4n+ 
carrying a 3 ‘-noncoding sequence was also used. The restriction 
fragments used were the PstI(678)/~acII(lO33) fragment or the 
Bgn1(1656)/SphI(2227) fragment from plasmid pmACR84 [2] 
carrying the porcine mAChR I cDNA, the Rsa1(708)/ 
SmaI(1142) fragment from plasmid pSPHMl0 [9] carrying the 
porcine mAChR II cDNA, the RsuI(784)/Ba11(1391) fragment 
from plasmid pSpmACR7 [8] carrying the porcine mAChR III 
genomic DNA, the Aut1(806)/Bgfl(1385) fragment from 
plasmid pSPRM3 [8] carrying the rat mAChR III genomic 
DNA [5] and the XhoI(786)/SmuI(1178) fragment from 
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plasmid pSPRM4 [8] carrying the rat mAChR IV genomic DNA 
[5]; restriction endonuclease sites are identified by numbers (in 
parentheses) indicating the 5’.terminal nucleotide generated by 
cleavage; nucleotide residues are numbered in the 5 ’ to 3 ’ direc- 
tion, beginning with the first residue of the ATG triplet en- 
coding the initiating methionine. The probes were labelled by 
nick-translation [22] with [e-‘*P]dCTP, their specific activities 
being 1.8-2.1 x IO8 cpm/pg. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the results of blot hybridization 
analysis of poly(A)+ RNA from various porcine 
(A-C) and rat tissues (D,E) using probes specific 
for the individual mRNAs encoding mAChR I (A), 
II (B), III (C,D) or IV (E). A single major 
hybridizable RNA species was observed with each 
probe. The estimated sizes of the major RNA 
species encoding porcine mAChR I, II and III, and 
rat mAChR III and IV were -3000 [2], -6100 [3], 
-9000, -4500 [6,24] and -3300 nucleotides [6,24], 
respectively. 
As shown in fig.lA, the -3000-nucleotide por- 
cine RNA species hybridizable with the mAChR I- 
specific probe was present in cerebrum (lane l), 
lacrimal gland (lane 2) and parotid gland (lane 3), 
but was not detectable in trachea (lane 6), urinary 
bladder (lane 7) and heart (lane 8). A barely detec- 
table signal was observed for small (lane 4) and 
large intestines (lane 5). This may indicate the 
presence of minute amounts of the mAChR I 
mRNA in intestines or may alternatively be at- 
tributable to the mAChR I mRNA derived from 
coexisting neural tissue. On the other hand, the 
-6100-nucleotide porcine RNA species hybri- 
dizable with the mAChR II-specific probe was 
found in all smooth muscles examined (fig.lB, 
lanes 4-7) as well as in heart (lane 8) and cerebrum 
(lane l), but not in exocrine glands (lanes 2,3). The 
-9000-nucleotide porcine RNA species hybri- 
dizable with the mAChR III-specific probe was 
present in exocrine glands (fig.lC, lanes 2,3) and 
smooth muscles (lanes 4-7) as well as in cerebrum 
(lane l), but was not detectable in heart (lane 8). 
Minor RNA species of smaller sizes observed with 
this probe may arise from polyadenylation at dif- 
ferent sites or from alternative RNA splicing. The 
-4500-nucleotide rat RNA species hybridizable 
with the mAChR III-specific probe showed a 
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Fig.]. Autoradiograms of blot hybridization analysis of 
poly(A)’ RNA from porcine (A-C) and rat tissues (D,E) using 
probes specific for the mRNAs encoding porcine mAChR 1 (A), 
porcine mAChR II (B), porcine mAChR III (C), rat mAChR III 
(D) or rat mAChR IV (E). (A-C) Analysis of poly(A)+ RNA 
(15 pg each) from porcine cerebrum (lane I), lacrimal gland 
(lane 2), parotid gland (lane 3). small intestine (lane 4), large 
intestine (lane 5), trachea (lane 6), urinary bladder (lane 7) and 
atrium (lane 8). (D,E) Analysis of poly(A)+ RNA (15 pg each) 
from rat cerebrum (lane l), submandibular gland (lane 2), small 
intestine (lane 3), trachea (lane 4), urinary bladder (lane 5) and 
heart (lane 6). Autoradiography was performed at - 70°C for 
70 h with an intensifying screen. The size markers used were 
porcine (or rat) and Escherichia co/i rRNAs [23]. The mAChR 
I-specific probe used in the experiment shown in (A) was the 
restriction fragment derived from the 3 ’ -noncoding region; 
similar results were obtained with the probe derived from the 
region between the putative transmembrane segments V and VI. 
For further details, see section 2. 
mandibular gland (fig.lD, lane 2), small intestine 
(lane 3), trachea (lane 4), urinary bladder (lane 5) 
and cerebrum (lane l), but not detectable in heart 
(lane 6). The -3300-nucleotide rat RNA species 
hybridizable with the mAChR IV-specific probe 
was found in cerebrum (fig.lE, lane l), but not in 
submandibular gland (lane 2), smooth muscles 
(lanes 3-5) and heart (lane 6). 
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The above results indicate that exocrine glands 
contain both the mAChR I and III mRNAs, 
whereas smooth muscles contain both mAChR II 
and III mRNAs. Exocrine glands and smooth 
muscles are representative sites for the phar- 
macologically defined MZ glandular subtype of the 
mAChR [ 11,121. Thus, the presence of mAChR III 
mR%(A in both tissues conforms with the finding 
that mAChR III corresponds most closely to the 
M2 glandular subtype in antagonist binding pro- 
perties [8]. It has previously been reported that rat 
pancreas contains mAChR III mRNA, but not 
mAChR I mRNA [6]. The presence of all four 
mAChR mRNAs in cerebrum agrees with previous 
observations as does the presence of mAChR II 
mRNA in heart [2,3,5,6,24]. The differential tissue 
distribution of the four mAChR mRNAs observed 
in the present investigation strengthens our 
previous conclusion that the mAChR heterogenei- 
ty in tissues with respect to antagonist binding is 
attributable to the presence of individual 
moIecuIarly distinct mAChR subtypes or various 
combinations of them [8]. 
activates principally Na+ and K+ currents [9], it is 
Activation of mAChRs enhances ecretion in ex- 
ocrine glands and generally evokes contraction of 
smcoo2h mushe >1). Dur TES&S may in&lcare Yna\ 
the mAChR I and III subtypes are responsible for 
secretion in exucrine glands and that Ihe mAChIt 
II zin+ z+ s3kP~yLps iax? k%%i~~~& ;kT 2?zWi&Cii a+ 
smooth muscle. It has recently been shown that the 
mAChR I and III subtypes are coupled efficiently 
with phosphoinositide hydrolysis, whereas the 
mAChR II and IV subtypes are Linked preferential- 
ly witzl actenylate cyclase inhibihx2 I25,26). Rx- 
thermore, the mAChR I and III subtypes expressed 
in NG108-15 neuroblastoma-glioma hybrid cells 
have been revealed to mediate inhibition of the M- 
current [16]. Most likely, activation of the mAChR 
I and III subtypes in exocrine glands enhances 
secretion at least partly through stimulation of 
phosphoinositide hydrolysis and consequent 
mcbilizatiaK aE intracellular Ca2+ (2J(. The 
mAChR III subtype may mediate contraction of 
smooth muscle both through mobilization of in- 
tracellular Ca2+ induced by phosphoinositide 
hydrolysis [26] and through increased influx of ex- 
tracellular Ca2+ resulting from inhibition of the M- 
current followed by membrane depolarization 
[27j: oh view of our previ‘ous- u-ihmai-m d-d-c tik- 
mAChR II subtype expressed in Xenopus oocytes 
possible that this subtype is also involved in con- 
traction of smooth muscle through activation of a 
nonselective cation channel [28]. 
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